ReCQC: A Novel NMR Data Analysis Platform Leveraging 13 C NMR and HSQC Database Strategies for Natural Product Dereplication
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c05654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Tingcai Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource, Yunnan Characteristic Plant Extraction Laboratory, Functional Molecules Analysis and Biot…. Hauptthemen laut MEDLINE: Biological Products, Software, Carbon-13 Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Science Research Foundation of Yunnan Education Bureau, China Tobacco Yunnan Industrial Corp, National Natural Science Foundation of China.
Abstract (Originalsprache)
Leveraging 13C NMR spectroscopic data, in this study, an innovative methodology is proposed for the efficient and accurate elucidation of the skeletal structures of target components within complex mixtures through the identification of maximum substructures and implementation of dynamic scoring. This approach not only facilitates targeted compound isolation but also enables iterative optimization of scoring outcomes. Using this approach, the team developed ReCQC 1.0, a publicly accessible software platform for mixture dereplication. To further increase analytical precision, advanced research was conducted to refine the scoring algorithm through the incorporation of carbon chemical environment descriptors integrated with Euclidean distance-based metrics derived from HSQC correlations, culminating in the development of ReCQC 2.0. Both software iterations feature intuitive graphical user interfaces designed for operational efficiency and accessibility. Comprehensive recovery experiments demonstrate the superior performance of the ReCQC framework compared with conventional dereplication strategies. Validation through chemical profiling of Pueraria lobata and Nicotiana tabacum enabled the identification of 25 constituent compounds, establishing a robust analytical pipeline for natural product mixture characterization and providing a valuable reference for future research endeavors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Yunnan Characteristic Plant Extraction Laboratory, Functional Molecules Analysis and Biotransformation Key Laboratory of Universities in Yunnan Province, Schoo…
- Yunnan Key Laboratory of Chinese Medicine Processing, College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, China.
ORCID-Profile: Feng Hao, Zhongtao Ding, Le Cai
Förderung
- Science Research Foundation of Yunnan Education Bureau
- China Tobacco Yunnan Industrial Corp
- National Natural Science Foundation of China
- Science and Technology Projects of Yunnan Universities Serving Key Industries
- Yunnan Characteristic Plant Screening and Research and Development Service CXO Platform
- Science and Technology Program of Yunnan Universities for Serving Key Industries
Zitieren
APA
Dong, T., Zhang, S., Zi, Y., Li, X., Yao, S., Hao, F., Zhu, L., Ding, Z., & Cai, L. (2026). ReCQC: A Novel NMR Data Analysis Platform Leveraging 13 C NMR and HSQC Database Strategies for Natural Product Dereplication. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c05654
Vancouver
Dong T, Zhang S, Zi Y, Li X, Yao S, Hao F, et al. ReCQC: A Novel NMR Data Analysis Platform Leveraging 13 C NMR and HSQC Database Strategies for Natural Product Dereplication. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c05654
BibTeX
@article{Dong2026,
author = {Dong, Tingcai and Zhang, Shengqi and Zi, Yongfan and Li, Xiya and Yao, Shu and Hao, Feng and Zhu, Li and Ding, Zhongtao and Cai, Le},
title = {ReCQC: A Novel NMR Data Analysis Platform Leveraging 13 C NMR and HSQC Database Strategies for Natural Product Dereplication},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c05654}
}
EUVIMED